| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,067 |
18,134 |
$770K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,735 |
6,722 |
$414K |
| S9083 |
Global fee urgent care centers |
5,966 |
4,467 |
$351K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,935 |
6,637 |
$178K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,014 |
1,764 |
$148K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,061 |
1,059 |
$79K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
460 |
426 |
$51K |
| 99215 |
Prolong outpt/office vis |
589 |
583 |
$36K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
548 |
546 |
$20K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,006 |
2,921 |
$54.16 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,416 |
2,381 |
$41.80 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,312 |
1,227 |
$38.28 |
| 99000 |
|
6,395 |
6,261 |
$12.60 |
| 81002 |
|
1,643 |
1,613 |
$2.15 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,259 |
1,197 |
$0.32 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
180 |
90 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
176 |
172 |
$0.00 |
| 94760 |
|
477 |
423 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
519 |
475 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
166 |
149 |
$0.00 |
| 87807 |
|
12 |
12 |
$0.00 |
| 94761 |
|
159 |
147 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
31 |
30 |
$0.00 |